Funds' Flonase Antitrust Suit Survives GSK Dismissal Bid
A Pennsylvania federal judge on Monday issued a split ruling on GlaxoSmithKline PLC's bid for summary judgment in four health care funds' antitrust class action alleging it improperly delayed sales of...To view the full article, register now.
Already a subscriber? Click here to view full article